Pediatric Mesenchymal Stem Cells Exhibit Immunomodulatory Properties Toward Allogeneic T and B Cells Under Inflammatory Conditions

被引:22
作者
Cabeza, Virginia Palomares [1 ,2 ,3 ]
Hoogduijn, Martin Johannes [2 ]
Kraaijeveld, Rens [2 ]
Franquesa, Marcella [4 ,5 ,6 ]
Witte-Bouma, Janneke [1 ]
Wolvius, Eppo B. [1 ]
Farrell, Eric [1 ]
Brama, Pieter A. J. [3 ]
机构
[1] Erasmus Univ, Dept Oral & Maxiliofacial Surg, Med Ctr, Rotterdam, Netherlands
[2] Erasmus Univ, Dept Internal Med, Nephrol & Transplantat, Med Ctr, Rotterdam, Netherlands
[3] Univ Coll Dublin, Sch Vet Med, Dublin, Ireland
[4] Germans Trias i Pujol Hlth Sci Inst, REMAR Grp, Badalona, Spain
[5] Germans Trias i Pujol Hlth Sci Inst, Nephrol Serv, Badalona, Spain
[6] Univ Hosp, Badalona, Spain
关键词
mesenchymal stem cell; immunomodulation; allogeneic; T cell; B cell; inflammatory microenvironment; INTERFERON-GAMMA; STROMAL CELLS; ADIPOSE-TISSUE; SUPPRESSION; CAPACITY; SURVIVAL;
D O I
10.3389/fbioe.2019.00142
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mesenchymal stem cells from pediatric patients (pMSCs) are an attractive cell source in regenerative medicine, due to their higher proliferation rates and better differentiation abilities compared to adult MSCs (aMSCs). We have previously characterized the immunomodulatory abilities of pMSCs on T cells under co-culture. It has also been reported that aMSCs can inhibit B cell proliferation and maturation under inflammatory conditions. In this study, we therefore aimed to clarify the immunomodulatory effect of pMSCs toward T and B cells in an inflammatory microenvironment. Bone marrow derived pMSCs were primed to simulate inflammatory conditions by exposure with 50 ng/mL of IFN-gamma for 3 days. To analyze the interaction between pMSCs and T cells, CD3/CD28 stimulated peripheral blood mononuclear cells (PBMCs) were co-cultured with primed or unprimed pMSCs. To investigate B cell responses, quiescent B cells obtained from spleens by CD43 negative selection were stimulated with anti-IgM, anti-CD40, IL-2, and co-cultured with either IFN-gamma primed or unprimed pMSC. pMSC phenotype, B and T cell proliferation, and B cell functionality were analyzed. Gene expression of indoleamine 2,3-dioxygenease (IDO), as well as the expression of HLA-ABC, HLA-DR and the co-stimulatory molecules CD80 and CD86 was upregulated on pMSCs upon IFN-gamma priming. IFN-gamma did not alter the immunomodulatory abilities of pMSCs upon CD4(+) nor CD8(+) stimulated T cells compared to unprimed pMSCs. IFN-y primed pMSCs but not unprimed pMSCs strongly inhibited naive (CD19(+)CD27(-)), memory (CD19(+)CD27(+)), and total B cell proliferation. Antibody-producing plasmablast (CD19(+)CD27(high)CD38(high)) formation and IgG production were also significantly inhibited by IFN-gamma primed pMSCs compared to unprimed pMSCs. Collectively, these results show that pMSCs have immunomodulatory effects upon the adaptive immune response which can be potentiated by inflammatory stimuli. This knowledge is useful in regenerative medicine and allogeneic transplantation applications toward tailoring pMSCs function to best modulate the immune response for a successful implant engraftment and avoidance of a strong immune reaction.
引用
收藏
页数:10
相关论文
共 39 条
  • [1] Mesenchymal stem cells in joint disease and repair
    Barry, Frank
    Murphy, Mary
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (10) : 584 - 594
  • [2] Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
    Bartholomew, A
    Sturgeon, C
    Siatskas, M
    Ferrer, K
    McIntosh, K
    Patil, S
    Hardy, W
    Devine, S
    Ucker, D
    Deans, R
    Moseley, A
    Hoffman, R
    [J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) : 42 - 48
  • [3] MSC-based therapies in solid organ transplantation
    Benseler, V.
    Obermajer, N.
    Johnson, C. L.
    Soeder, Y.
    Dahlke, M. D.
    Popp, F. C.
    [J]. HEPATOLOGY INTERNATIONAL, 2014, 8 (02) : 179 - 184
  • [4] Mesenchymal stem cells: Revisiting history, concepts, and assays
    Bianco, Paolo
    Robey, Pamela Gehron
    Simmons, Paul J.
    [J]. CELL STEM CELL, 2008, 2 (04) : 313 - 319
  • [5] Regenerative Potential of Mesenchymal Stromal Cells: Age-Related Changes
    Bruna, Flavia
    Contador, David
    Conget, Paulette
    Erranz, Benjamin
    Sossa, Claudia L.
    Arango-Rodriguez, Martha L.
    [J]. STEM CELLS INTERNATIONAL, 2016, 2016
  • [6] Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing
    Chamberlain, Giselle
    Fox, James
    Ashton, Brian
    Middleton, Jim
    [J]. STEM CELLS, 2007, 25 (11) : 2739 - 2749
  • [7] IDO-Independent Suppression of T Cell Effector Function by IFN-γ-Licensed Human Mesenchymal Stromal Cells
    Chinnadurai, Raghavan
    Copland, Ian B.
    Patel, Seema R.
    Galipeau, Jacques
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 192 (04) : 1491 - 1501
  • [8] Human mesenchymal stem cells modulate B-cell functions
    Corcione, A
    Benvenuto, F
    Ferretti, E
    Giunti, D
    Cappiello, V
    Cazzanti, F
    Risso, M
    Gualandi, F
    Mancardi, GL
    Pistoia, V
    Uccelli, A
    [J]. BLOOD, 2006, 107 (01) : 367 - 372
  • [9] Enhancing Retention of Mesenchymal Stem Cells with Prosurvival Factors Promotes Angiogenesis in a Mouse Model of Limb Ischemia
    Cortez-Toledo, Elizabeth
    Rose, Melanie
    Agu, Emmanuel
    Dahlenburg, Heather
    Yao, Wei
    Nolta, Jan A.
    Zhou, Ping
    [J]. STEM CELLS AND DEVELOPMENT, 2019, 28 (02) : 114 - 119
  • [10] The mechanisms of rejection in solid organ transplantation
    Cozzi, Emanuele
    Colpo, Anna
    De Silvestro, Giustina
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (04) : 498 - 505